European Clinical Guidelines for Tourette Syndrome and Other Tic Disorders – version 2.0. Part IV: Deep Brain Stimulation

Autor: Andreas Hartmann, Cécile Delorme, Mauro Porta, Natalia Szejko, Jens Kuhn, Kirsten R. Müller-Vahl, Albert F.G. Leentjens, Jan-Hinnerk Mehrkens, Yulia Worbe, Linda Ackermans, Daniel Huys, Juan Carlos Baldermann, Christos Ganos, Thomas Foltynie, Andrea E. Cavanna, Carine Karachi, Veerle Visser-Vandewalle, Danielle C. Cath
Přispěvatelé: Szejko, N, Worbe, Y, Hartmann, A, Visser Vandewalle, V, Ackermans, L, Ganos, C, Porta, M, Leentjens, A, Mehrkens, J, Huys, D, Baldermann, J, Kuhn, J, Karachi, C, Delorme, C, Foltynie, T, Cavanna, A, Cath, D, Müller-Vahl, K, Medical University of Warsaw - Poland, Yale University School of Medicine, Unité de neurophysiologie [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre De Référence National 'Syndrome Gilles de la Tourette', Pôle des Maladies du Système Nerveux [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Service de Neurochirurgie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], University Hospital of Cologne [Cologne], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], IRCCS Istituto Ortopedico Galeazzi, Ludwig-Maximilians-Universität München (LMU), Service de Neurologie [CHU Pitié-Salpêtrière], IFR70-CHU Pitié-Salpêtrière [AP-HP], University College of London [London] (UCL), University of Birmingham [Birmingham], University Medical Center Groningen [Groningen] (UMCG), Hannover Medical School [Hannover] (MHH), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Databases
Factual
ASSESSMENT RECOMMENDATIONS
medicine.medical_treatment
Guideline
Tourette syndrome
law.invention
DOUBLE-BLIND
0302 clinical medicine
Randomized controlled trial
QUALITY-OF-LIFE
law
Developmental and Educational Psychology
Child and adolescent psychiatry
Deep brain stimulation
Registries
THALAMIC-STIMULATION
0303 health sciences
General Medicine
3. Good health
Psychiatry and Mental health
Tolerability
Tics
TRIAL
European Society for the Study of Tourette Syndrome (ESSTS)
medicine.medical_specialty
LONG-TERM
NUCLEUS-ACCUMBENS
Guidelines
Placebo
PATIENT SELECTION
03 medical and health sciences
medicine
Humans
Intensive care medicine
TERM-FOLLOW-UP
030304 developmental biology
GLOBUS-PALLIDUS INTERNUS
Tic
business.industry
medicine.disease
Treatment
Tic Disorders
Treatment of Tourette syndrome
Pediatrics
Perinatology and Child Health
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
030217 neurology & neurosurgery
Zdroj: European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, Springer Verlag (Germany), 2021, ⟨10.1007/s00787-021-01881-9⟩
ISSN: 1018-8827
DOI: 10.1007/s00787-021-01881-9⟩
Popis: In 2011 the European Society for the Study of Tourette Syndrome (ESSTS) published its first European clinical guidelines for the treatment of Tourette Syndrome (TS) with part IV on deep brain stimulation (DBS). Here, we present a revised version of these guidelines with updated recommendations based on the current literature covering the last decade as well as a survey among ESSTS experts. Currently, data from the International Tourette DBS Registry and Database, two meta-analyses, and eight randomized controlled trials (RCTs) are available. Interpretation of outcomes is limited by small sample sizes and short follow-up periods. Compared to open uncontrolled case studies, RCTs report less favorable outcomes with conflicting results. This could be related to several different aspects including methodological issues, but also substantial placebo effects. These guidelines, therefore, not only present currently available data from open and controlled studies, but also include expert knowledge. Although the overall database has increased in size since 2011, definite conclusions regarding the efficacy and tolerability of DBS in TS are still open to debate. Therefore, we continue to consider DBS for TS as an experimental treatment that should be used only in carefully selected, severely affected and otherwise treatment-resistant patients.
Databáze: OpenAIRE
Externí odkaz: